Literature DB >> 24381070

Gene expression profiling analysis reveals that DLG3 is down-regulated in glioblastoma.

Zhongyu Liu1, Yulong Niu, Mengyu Xie, Youquan Bu, Zhiqiang Yao, Chunfang Gao.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant glioma. In the current study, 149 astrocytoma gene expression datasets were classified by prediction analysis of microarray. Strikingly, disks large homolog 3 (DLG3), a membrane-associated guanylate kinase-family gene, had the highest score in the GBM subset. DLG3 mRNA expression is significantly down-regulated in GBM relative to normal tissue and grade II or grade III astrocytoma according to the results of real-time polymerase chain reaction, and its protein expression shows an obvious difference by immunohistochemistry. Further assays show that DLG3 over-expression induces mitotic cell cycle arrest and apoptosis, and it inhibits proliferation and migration. However, DLG3 over-expression has almost no affect on invasion. The DLG3 protein expression in human brain GBM tissue and its effects on GBM cell invasion were not expected. Our data suggest that DLG3 is down-regulated in this cancer type. To our knowledge, this is the first report to clearly demonstrate the possible involvement of DLG3 in GBM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24381070     DOI: 10.1007/s11060-013-1325-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The genetic control of cell proliferation in Drosophila imaginal discs.

Authors:  P J Bryant; O Schmidt
Journal:  J Cell Sci Suppl       Date:  1990

3.  Recognition of unique carboxyl-terminal motifs by distinct PDZ domains.

Authors:  Z Songyang; A S Fanning; C Fu; J Xu; S M Marfatia; A H Chishti; A Crompton; A C Chan; J M Anderson; L C Cantley
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

4.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

Review 5.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 6.  The significance of the Wnt pathway in the pathology of human cancers.

Authors:  Rooshdiya Karim; Gary Tse; Thomas Putti; Richard Scolyer; Soon Lee
Journal:  Pathology       Date:  2004-04       Impact factor: 5.306

7.  Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg.

Authors:  Hiroshi Fukuhara; Mari Masuda; Mika Yageta; Takeshi Fukami; Masami Kuramochi; Tomoko Maruyama; Tadaichi Kitamura; Yoshinori Murakami; Mari Masvuda
Journal:  Oncogene       Date:  2003-09-18       Impact factor: 9.867

Review 8.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

9.  Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95.

Authors:  Heike Hering; Morgan Sheng
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

10.  Dlg3 trafficking and apical tight junction formation is regulated by nedd4 and nedd4-2 e3 ubiquitin ligases.

Authors:  Claude A Van Campenhout; Andrea Eitelhuber; Christian J Gloeckner; Patrizia Giallonardo; Moritz Gegg; Heide Oller; Seth G N Grant; Daniel Krappmann; Marius Ueffing; Heiko Lickert
Journal:  Dev Cell       Date:  2011-09-13       Impact factor: 12.270

View more
  8 in total

1.  The scaffolding protein DLG5 promotes glioblastoma growth by controlling Sonic Hedgehog signaling in tumor stem cells.

Authors:  Somanath Kundu; Mohan S Nandhu; Sharon L Longo; John A Longo; Shawn Rai; Lawrence S Chin; Timothy E Richardson; Mariano S Viapiano
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

2.  Expression of polarity genes in human cancer.

Authors:  Wan-Hsin Lin; Yan W Asmann; Panos Z Anastasiadis
Journal:  Cancer Inform       Date:  2015-03-30

3.  A composite network of conserved and tissue specific gene interactions reveals possible genetic interactions in glioma.

Authors:  André Voigt; Katja Nowick; Eivind Almaas
Journal:  PLoS Comput Biol       Date:  2017-09-28       Impact factor: 4.475

4.  Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.

Authors:  Jie Liu; Juan Li; Pingping Li; Yaochun Wang; Zheyong Liang; Yina Jiang; Jing Li; Chen Feng; Ruiqi Wang; He Chen; Can Zhou; Jianmin Zhang; Jin Yang; Peijun Liu
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

5.  Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species.

Authors:  J Manent; S Banerjee; R de Matos Simoes; T Zoranovic; C Mitsiades; J M Penninger; K J Simpson; P O Humbert; H E Richardson
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

6.  High expression of DLG3 is associated with decreased survival from breast cancer.

Authors:  Jie Liu; Pingping Li; Ruiqi Wang; Juan Li; Miao Zhang; Zhangjun Song; Peijun Liu
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-07-31       Impact factor: 2.557

7.  Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression.

Authors:  Bingbing Liu; Yanning Xu; Lin Zhang; Xue Yang; Ling Chen; Yixin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-02       Impact factor: 2.629

8.  Hippocampal transcriptome analysis following maternal separation implicates altered RNA processing in a mouse model of fetal alcohol spectrum disorder.

Authors:  Bonnie L J Alberry; Christina A Castellani; Shiva M Singh
Journal:  J Neurodev Disord       Date:  2020-05-16       Impact factor: 4.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.